Literature DB >> 11123323

Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.

O Neyrolles1, K Gould, M P Gares, S Brett, R Janssen, P O'Gaora, J L Herrmann, M C Prévost, E Perret, J E Thole, D Young.   

Abstract

Following uptake by macrophages, live mycobacteria initially reside within an immature phagosome that resists acidification and retains access to recycling endosomes. Glycolipids are exported from the mycobacterial phagosome and become available for immune recognition by CD1-restricted T cells. The aim of this study was to explore the possibility that lipoproteins might similarly escape from the phagosome and act as immune targets in cells infected with live mycobacteria. We have focused on a 19-kDa lipoprotein from Mycobacterium tuberculosis that was previously shown to be recognized by CD8(+) T cells. The 19-kDa Ag was found to traffic separately from live mycobacteria within infected macrophages by a pathway that was dependent on acylation of the protein. When expressed as a recombinant protein in rapid-growing mycobacteria, the 19-kDa Ag was able to deliver peptides for recognition by MHC class I-restricted T cells by a TAP-independent mechanism. Entry into the class I pathway was rapid, dependent on acylation, and could be blocked by killing the mycobacteria by heating before infection. Although the pattern of 19-kDa trafficking was similar with different mycobacterial species, preliminary experiments suggest that class I presentation is more efficient during infection with rapid-growing mycobacteria than with the slow-growing bacillus Calmette-Guérin vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11123323     DOI: 10.4049/jimmunol.166.1.447

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  Bugs as drugs for cancer.

Authors:  Eleanor J Cheadle; Andrew M Jackson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

2.  Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Authors:  Mark J Cayabyab; Avi-Hai Hovav; Tsungda Hsu; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Glenn J Fennelly; Barton F Haynes; William R Jacobs; Norman L Letvin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Mycobacterium tuberculosis (Mtb) lipid mediated lysosomal rewiring in infected macrophages modulates intracellular Mtb trafficking and survival.

Authors:  Kuldeep Sachdeva; Manisha Goel; Malvika Sudhakar; Mansi Mehta; Rajmani Raju; Karthik Raman; Amit Singh; Varadharajan Sundaramurthy
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.

Authors:  Avi-Hai Hovav; Mark J Cayabyab; Michael W Panas; Sampa Santra; John Greenland; Ralf Geiben; Barton F Haynes; William R Jacobs; Norman L Letvin
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

5.  Anti-tuberculosis immunity induced in mice by vaccination with Mycobacterium smegmatis over-expressing Antigen 85B is due to the increased influx of IFNgamma-positive CD4 T cells into the lungs.

Authors:  Devin R Lindsey; Subramanian Dhandayuthapani; Chinnaswamy Jagannath
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

Review 6.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

8.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques.

Authors:  Jaimie D Sixsmith; Michael W Panas; Sunhee Lee; Geoffrey O Gillard; KeriAnn White; Michelle A Lifton; Harikrishnan Balachandran; Linh Mach; John P Miller; Christy Lavine; C Todd DeMarco; Georgia D Tomaras; Connie Gee; Steven A Porcelli; Michelle H Larsen; Richard Frothingham; Joern E Schmitz; William R Jacobs; Barton F Haynes; Norman L Letvin; Birgit Korioth-Schmitz
Journal:  Clin Vaccine Immunol       Date:  2014-07-30

9.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

10.  Genetic determination of the effect of post-translational modification on the innate immune response to the 19 kDa lipoprotein of Mycobacterium tuberculosis.

Authors:  Katalin A Wilkinson; Sandra M Newton; Graham R Stewart; Adrian R Martineau; Janisha Patel; Susan M Sullivan; Jean-Louis Herrmann; Olivier Neyrolles; Douglas B Young; Robert J Wilkinson
Journal:  BMC Microbiol       Date:  2009-05-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.